Lecture 2. Regulatory view of imaging biomarkers for prostate cancer care

Lecture 3 - Building the clinical value of imaging biomarkers for prostate cancerПодробнее

Oxford University surgical lectures: Diagnosing and managing early prostate cancerПодробнее

Biomarkers’ Integration with Clinical Parameters, Imaging, and Prognostic InstrumentsПодробнее

2021 PKD Regulatory Summit: Clinical trial design in PKD: early TKV modeling for trial enrichmentПодробнее

Molecular PSMA Imaging and Targeted Radionuclide Therapy of Metastatic Prostate CancerПодробнее

Personalizing Prostate Cancer Diagnosis using Imaging BiomarkersПодробнее

Active Surveillance in 2021 Part 2: Imaging and BiomarkersПодробнее

Lecture 1. Introducing imaging biomarkers for prostate cancer careПодробнее

Hyperpolarized Molecular Imaging Biomarkers and Prostate CancerПодробнее

Biomarkers and Molecular Imaging for Prostate CancerПодробнее

Integrating MRI and Molecular Markers to Detect Aggressive Prostate CancerПодробнее

Engineering the future of imaging-based diagnostics and therapeutics for prostate cancerПодробнее

MRI-invisible Prostate Cancer and Use of Biomarkers to Identify Potential CandidatesПодробнее

In My Opinion: Biomarkers for the Diagnosis of Prostate CancerПодробнее

PSA limitations in prostate cancer: advancing treatment de-escalation with imaging biomarkersПодробнее

Image-Guided Focal Treatment of Prostate CancerПодробнее

Industry Perspective: Personalization of Prostate Cancer Care Through Integration of DataПодробнее

Highlights from PROSCA 2018: Imaging, biomarkers and genetic testingПодробнее

Assessing the pitfalls of next-generation imaging tools in prostate cancerПодробнее

Biomarkers: A Way Forward with Prostate Cancer Early DetectionПодробнее